United Therapeutics Corporation · NASDAQ:UTHR

Rothblatt Martine A sold 9,500 United Therapeutics Corporation shares (Form 4)

Traded Apr 24, 2026 · Filed Apr 27, 2026

On Apr 24, 2026, Rothblatt Martine A (Director, Chairperson & CEO) sold 9,500 United Therapeutics Corporation shares at an average US$564.81 for US$5.37M under a trading plan, leaving 40,513 shares. Filed Apr 27, 2026 (Form 4).

Sold
9,500 shares
Price
US$564.81 average (US$561.21 to US$567.41)
Value
US$5.37M
Holding after
40,513 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairperson & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Apr 24, 2026Common StockOption exercise9,500US$146.0350,013Direct
Apr 24, 2026Common StockSale320US$561.2149,693Direct
Apr 24, 2026Common StockSale878US$562.3748,815Direct
Apr 24, 2026Common StockSale1,316US$563.4947,499Direct
Apr 24, 2026Common StockSale1,796US$564.5345,703Direct
Apr 24, 2026Common StockSale3,220US$565.3642,483Direct
Apr 24, 2026Common StockSale1,950US$566.7040,533Direct
Apr 24, 2026Common StockSale20US$567.4140,513Direct

Source

View original at SEC

Related